Renal Cancer

  • Afinitor 2014 report

    Afinitor 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 31 Pages The 5 Key Questions Addressed by this...

  • Avastin 2014 report

    Avastin 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 26 Pages The 5 Key Questions Addressed by this...

  • Inlyta 2014 report

    Inlyta 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this...

  • Nexavar 2014 report

    Nexavar 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 31 Pages The 5 Key Questions Addressed by this...

  • Proleukin 2014 report

    Proleukin 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 25 Pages The 5 Key Questions Addressed by this...

  • Sutent 2014 report

    Sutent 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this...

  • Torisel 2014 report

    Torisel 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this...

  • Votrient 2014 report

    Votrient 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 25 Pages The 5 Key Questions Addressed by this...